Cargando…
A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants
BACKGROUND: A vaccine to decrease transmission of human immunodeficiency virus type 1 (HIV-1) during breast-feeding would complement efforts to eliminate infant HIV-1 infection by antiretroviral therapy. Relative to adults, infants have distinct immune development, potentially high-risk of transmiss...
Autores principales: | Afolabi, Muhammed O., Ndure, Jorjoh, Drammeh, Abdoulie, Darboe, Fatoumatta, Mehedi, Shams-Rony, Rowland-Jones, Sarah L., Borthwick, Nicola, Black, Antony, Ambler, Gwen, John-Stewart, Grace C., Reilly, Marie, Hanke, Tomáš, Flanagan, Katie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813444/ https://www.ncbi.nlm.nih.gov/pubmed/24205185 http://dx.doi.org/10.1371/journal.pone.0078289 |
Ejemplares similares
-
PedVacc 002: A phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi
por: Njuguna, Irene N., et al.
Publicado: (2014) -
Newborn Mice Vaccination with BCG.HIVA(222) + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
por: Saubi, Narcís, et al.
Publicado: (2011) -
P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes
por: Saubi, N, et al.
Publicado: (2009) -
Targeting regulatory T cells to improve vaccine immunogenicity in early life
por: Ndure, Jorjoh, et al.
Publicado: (2014) -
Sex-Differential Impact of Human Cytomegalovirus Infection on In Vitro Reactivity to Toll-Like Receptor 2, 4 and 7/8 Stimulation in Gambian Infants
por: Cox, Momodou, et al.
Publicado: (2020)